These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 10563395)

  • 1. Immunity and vaccine development in the bovine theilerioses.
    Boulter N; Hall R
    Adv Parasitol; 1999; 44():41-97. PubMed ID: 10563395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Responses in animals vaccinated with the Theileria annulata (Hisar) cell culture vaccine.
    Beniwal RK; Nichani AK; Sharma RD; Rakha NK; Suri D; Sarup S
    Trop Anim Health Prod; 1997 Nov; 29(4 Suppl):109S-113S. PubMed ID: 9512755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Approaches to vaccination against Theileria parva and Theileria annulata.
    Nene V; Morrison WI
    Parasite Immunol; 2016 Dec; 38(12):724-734. PubMed ID: 27647496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptomics reveal potential vaccine antigens and a drastic increase of upregulated genes during Theileria parva development from arthropod to bovine infective stages.
    Tonui T; Corredor-Moreno P; Kanduma E; Njuguna J; Njahira MN; Nyanjom SG; Silva JC; Djikeng A; Pelle R
    PLoS One; 2018; 13(10):e0204047. PubMed ID: 30303978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of protective immunity to Theileria annulata using two major merozoite surface antigens presented by different delivery systems.
    d'Oliveira C; Feenstra A; Vos H; Osterhaus AD; Shiels BR; Cornelissen AW; Jongejan F
    Vaccine; 1997 Nov; 15(16):1796-804. PubMed ID: 9364686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization against diseases caused by Theileria parva: a review.
    Uilenberg G
    Trop Med Int Health; 1999 Sep; 4(9):A12-20. PubMed ID: 10540307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination against tropical theileriosis.
    Pipano E; Shkap V
    Ann N Y Acad Sci; 2000; 916():484-500. PubMed ID: 11193663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Transcriptomics of the Bovine Apicomplexan Parasite
    Atchou K; Ongus J; Machuka E; Juma J; Tiambo C; Djikeng A; Silva JC; Pelle R
    Front Vet Sci; 2020; 7():287. PubMed ID: 32582776
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification of candidate vaccine antigens of bovine hemoparasites Theileria parva and Babesia bovis by use of helper T cell clones.
    Brown WC; Zhao S; Logan KS; Grab DJ; Rice-Ficht AC
    Vet Parasitol; 1995 Mar; 57(1-3):189-203. PubMed ID: 7597783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status of vaccine development against Theileria parasites.
    Morrison WI; McKeever DJ
    Parasitology; 2006; 133 Suppl():S169-87. PubMed ID: 17274845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reciprocal cross-protection induced by sporozoite antigens SPAG-1 from Theileria annulata and p67 from Theileria parva.
    Hall R; Boulter NR; Brown CG; Wilkie G; Kirvar E; Nene V; Musoke AJ; Glass EJ; Morzaria SP
    Parasite Immunol; 2000 May; 22(5):223-30. PubMed ID: 10792761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and purification of glycosylphosphatidylinositols (GPIs) in the schizont stage of Theileria annulata and determination of antibody response to GPI anchors in vaccinated and infected animals.
    Abbasnia T; Asoodeh A; Habibi G; Haghparast A
    Parasit Vectors; 2018 Feb; 11(1):82. PubMed ID: 29409517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a Potential Yeast-Based Vaccine Platform for
    Goh S; Kolakowski J; Holder A; Pfuhl M; Ngugi D; Ballingall K; Tombacz K; Werling D
    Front Immunol; 2021; 12():674484. PubMed ID: 34305904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination of calves with an attenuated cell line of Theileria annulata and the sporozoite antigen SPAG-1 produces a synergistic effect.
    Darghouth MA; Boulter NR; Gharbi M; Sassi L; Tait A; Hall R
    Vet Parasitol; 2006 Nov; 142(1-2):54-62. PubMed ID: 16870344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccines against Theileria parva.
    Morzaria S; Nene V; Bishop R; Musoke A
    Ann N Y Acad Sci; 2000; 916():464-73. PubMed ID: 11193661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative evaluation of cell-mediated immune response in calves immunized with live-attenuated and killed Theileria annulata vaccines.
    Ramzan MS; Suleman M; Rashid MI; Akbar H; Avais M
    Parasitol Res; 2023 Sep; 122(9):2135-2145. PubMed ID: 37466666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of recombinant antigen vaccines for the control of theileriosis.
    Musoke AJ; Nene V
    Parassitologia; 1990 Apr; 32(1):73-85. PubMed ID: 2149448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum-free in vitro cultivation of Theileria annulata and Theileria parva schizont-infected lymphocytes.
    Zweygarth E; Nijhof AM; Knorr S; Ahmed JS; Al-Hosary ATA; Obara I; Bishop RP; Josemans AI; Clausen PH
    Transbound Emerg Dis; 2020 Mar; 67 Suppl 1():35-39. PubMed ID: 32174041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orientation of bovine CTL responses towards PIM, an antibody-inducing surface molecule of Theileria parva, by DNA subunit immunization.
    Ververken C; Geysen D; Loots K; Janssens ME; Guisez Y; Goddeeris BM
    Vet Immunol Immunopathol; 2008 Aug; 124(3-4):253-63. PubMed ID: 18466981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 32 kDa surface antigen of Theileria parva: characterization and immunization studies.
    Skilton RA; Musoke AJ; Wells CW; Yagi Y; Nene V; Spooner PR; Gachanja J; Osaso J; Bishop RP; Morzaria SP
    Parasitology; 2000 Jun; 120 ( Pt 6)():553-64. PubMed ID: 10874718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.